Current Advances in Epidemiology, Diagnosis, and Management of TAVR-Associated Infective Endocarditis: A Narrative Review.

Rev Cardiovasc Med · 2026 · PMC12873667 · PMID 41659087

Europe PMC DOI

hedged sentence

0.0500

closest p · 1.0× alpha

0.0500

boldest claim

The sentences

narrowly missed statistical significancep = 0.05actually significant

One study reported a higher overall IE risk among intermediate-risk patients undergoing TAVR (2.3%) compared to those receiving SAVR (1.2%), although this difference narrowly missed statistical significance (odds ratio: 1.92; 95% CI: 0.99–3.72; p = 0.05; I 2 = 0%) [ 17 ].

also in 227 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.